{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:01:16Z","timestamp":1774620076968,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04705-x","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:46:37Z","timestamp":1771652797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-9687","authenticated-orcid":false,"given":"Muhammet","family":"Cengiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3551-5234","authenticated-orcid":false,"given":"Oktay","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9133-8602","authenticated-orcid":false,"given":"Ay\u015fe","family":"Nuransoy Cengiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3737-3420","authenticated-orcid":false,"given":"Mevlude","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0359-0504","authenticated-orcid":false,"given":"Metin","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1008-2527","authenticated-orcid":false,"given":"Emel","family":"Mutlu Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-9467","authenticated-orcid":false,"given":"Deniz Can","family":"Guven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-4669","authenticated-orcid":false,"given":"Mustafa","family":"Erman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-1085","authenticated-orcid":false,"given":"Latif","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-3951","authenticated-orcid":false,"given":"Elif","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-266X","authenticated-orcid":false,"given":"An\u0131l","family":"Karakayali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5310-5557","authenticated-orcid":false,"given":"Pervin","family":"Can Sanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-5377","authenticated-orcid":false,"given":"Umut","family":"Kefeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-6311","authenticated-orcid":false,"given":"Devrim","family":"Cabuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-2479","authenticated-orcid":false,"given":"Erdem","family":"Kolemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-720X","authenticated-orcid":false,"given":"Mehmet Mutlu","family":"Kidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-0668","authenticated-orcid":false,"given":"Sedat","family":"Biter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-0525","authenticated-orcid":false,"given":"Tolga","family":"Koseci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-3398","authenticated-orcid":false,"given":"Muslih","family":"Urun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-5500","authenticated-orcid":false,"given":"Berrak","family":"Mermit Ercek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-263X","authenticated-orcid":false,"given":"Duygu","family":"Bayir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-6483","authenticated-orcid":false,"given":"G\u00f6zde","family":"Agdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-9414","authenticated-orcid":false,"given":"Teoman","family":"Sakalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-5819","authenticated-orcid":false,"given":"Nargiz","family":"Majidova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3817-8934","authenticated-orcid":false,"given":"Sedat","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1235-9363","authenticated-orcid":false,"given":"Hacer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-5550","authenticated-orcid":false,"given":"Cengiz","family":"Akosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-4846","authenticated-orcid":false,"given":"Mustafa","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-7390","authenticated-orcid":false,"given":"Saadettin","family":"Kilickap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-2904","authenticated-orcid":false,"given":"Erkam","family":"Kocaaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-7047","authenticated-orcid":false,"given":"Ezgi","family":"Turko\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-6902","authenticated-orcid":false,"given":"Sedat","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-5567","authenticated-orcid":false,"given":"Hayati","family":"Arvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-8741","authenticated-orcid":false,"given":"Havva","family":"Yesil Cinkir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1586-3868","authenticated-orcid":false,"given":"Aslihan Ezgi","family":"Apaydin Rollas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"2","key":"4705_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.21037\/tcr-23-1816","volume":"13","author":"S Alamri","year":"2024","unstructured":"Alamri S, Badah MZ, Zorgi S, Alenazi R, Alshanbari HM, Ali MAM, Murished G, Awadalla ME, Alshihre A, Alghareeb WA, Alosaimi B. Disease prognosis and therapeutic strategies in patients with advanced non-small cell lung cancer (NSCLC): a 6-year epidemiological study between 2015\u20132021. Transl Cancer Res. 2024;13(2):762\u201370.","journal-title":"Transl Cancer Res"},{"issue":"12","key":"4705_CR2","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","volume":"7","author":"AK Ganti","year":"2021","unstructured":"Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. JAMA Oncol. 2021;7(12):1824\u201332.","journal-title":"JAMA Oncol"},{"issue":"5","key":"4705_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/cncr.32624","volume":"126","author":"B Youn","year":"2020","unstructured":"Youn B, Trikalinos NA, Mor V, Wilson IB, Dahabreh IJ. Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non\u2013small cell lung cancer. Cancer. 2020;126(5):978\u201385.","journal-title":"Cancer"},{"issue":"14","key":"4705_CR4","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/1078-0432.CCR-16-0714","volume":"23","author":"JA Beaver","year":"2017","unstructured":"Beaver JA, Theoret MR, Mushti S, He K, Libeg M, Goldberg K, Sridhara R, McKee AE, Keegan P, Pazdur R. FDA approval of nivolumab for the first-line treatment of patients with BRAFV600 wild-type unresectable or metastatic melanoma. Clin Cancer Res. 2017;23(14):3479\u201383.","journal-title":"Clin Cancer Res"},{"key":"4705_CR5","doi-asserted-by":"publisher","unstructured":"Rajan A, Kim C, Heery CR, Guha U, Gulley JL. Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers. Hum Vaccines Immunother [Internet]. 2016;12(9):2219\u201331. Available from: https:\/\/doi.org\/10.1080\/21645515.2016.1175694","DOI":"10.1080\/21645515.2016.1175694"},{"issue":"3","key":"4705_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/PAS.0000000000000780","volume":"41","author":"EA Dill","year":"2017","unstructured":"Dill EA, Gru AA, Atkins KA, Friedman LA, Moore ME, Bullock TN, Cross JV, Dillon PM, Mills AM. PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages: An Assessment of 245 Primary and 40 Metastatic Tumors. Am J Surg Pathol. 2017;41(3):334\u201342.","journal-title":"Am J Surg Pathol"},{"key":"4705_CR7","doi-asserted-by":"crossref","unstructured":"Kumar A, Kapoor A, Noronha V, Patil VM, Joshi A, Menon N, Janu A, Mahajan A, Rajendra A, Agarawal A, Khaddar S, Rajpurohit A, Kashyap L, Srikant A, Panda G, Kota KK, Talreja V, Prabhash K. Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings. South Asian J Cancer. 2024;70\u20136.","DOI":"10.1055\/s-0044-1788649"},{"issue":"18","key":"4705_CR8","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1158\/1078-0432.CCR-16-2842","volume":"23","author":"Y Feng","year":"2017","unstructured":"Feng Y, Wang X, Bajaj G, Agrawal S, Bello A, Lestini B, Finckenstein FG, Park JS, Roy A. Nivolumab exposure\u2013response analyses of efficacy and safety in previously treated squamous or nonsquamous non\u2013small cell lung cancer. Clin Cancer Res. 2017;23(18):5394\u2013405.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4705_CR9","first-page":"68","volume":"34","author":"SY Disli","year":"2024","unstructured":"Disli SY, Ayas E, Disli AK, Ozdemir F. Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy. UHOD - Uluslararasi Hematol Derg. 2024;34(2):68\u201373.","journal-title":"UHOD - Uluslararasi Hematol Derg"},{"issue":"3","key":"4705_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jamaoncol.2017.4771","volume":"4","author":"L Mezquita","year":"2018","unstructured":"Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zer\u00f3n-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B. Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer. JAMA Oncol. 2018;4(3):351\u20137.","journal-title":"JAMA Oncol"},{"issue":"6","key":"4705_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","volume":"89","author":"LM Forrest","year":"2003","unstructured":"Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028\u201330.","journal-title":"Br J Cancer"},{"issue":"35","key":"4705_CR12","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1200\/JCO.2017.74.3062","volume":"35","author":"L Horn","year":"2017","unstructured":"Horn L, Spigel DR, Vokes EE, Holgado E, Ready N, Steins M, Poddubskaya E, Borghaei H, Felip E, Paz-Ares L, Pluzanski A, Reckamp KL, Burgio MA, Kohlh\u00e4eufl M, Waterhouse D, Barlesi F, Antonia S, Arrieta O, Fayette J, Crin\u00f2 L, Rizvi N, Reck M, Hellmann MD, Geese WJ, Li A, Blackwood-Chirchir A, Healey D, Brahmer J, Eberhardt WEE. Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: Two-year outcomes from two randomized, open-label, phase III Trials (CheckMate 017 and CheckMate 057). J Clin Oncol. 2017;35(35):3924\u201333.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4705_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","volume":"19","author":"DG Altman","year":"2000","unstructured":"Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19(4):453\u201373.","journal-title":"Stat Med"},{"issue":"2","key":"4705_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crin\u00f2 L, Eberhardt WEE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, Ar\u00e9n Frontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, Harbison CT, Lestini B, Spigel DR. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2015;373(2):123\u201335.","journal-title":"N Engl J Med"},{"issue":"4","key":"4705_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1620\/tjem.236.297","volume":"236","author":"X Hong","year":"2015","unstructured":"Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236(4):297\u2013304.","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"4705_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/1759-7714.14798","volume":"14","author":"K Sonehara","year":"2023","unstructured":"Sonehara K, Ozawa R, Hama M, Nozawa S, Agatsuma T, Nishie K, Kato A, Matsuo A, Araki T, Komatsu M, Tateishi K, Hanaoka M. C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study. Thorac Cancer. 2023;14(6):636\u201342.","journal-title":"Thorac Cancer"},{"issue":"19","key":"4705_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O\u2019Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR. Pembrolizumab versus Chemotherapy for PD-L1\u2013Positive Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2016;375(19):1823\u201333.","journal-title":"N Engl J Med"},{"key":"4705_CR18","doi-asserted-by":"publisher","unstructured":"Mezquita L, Auclin E, Charrier M, Ferrara R, Remon Masip J, Planchard D, Ponce Aix S, Paz-Ares L, Lahmar J, Leroy L, Audigier-Valette C, Zeron-Medina Cuairan J, Garrido Lopez P, Brosseau S, Mazieres J, Caramella C, Adam J, Chaput N, Soria J-C, Besse B. The Lung Immune Prognostic Index (LIPI), a predictive score for immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) patients. Ann Oncol [Internet]. 2017;28(September):v473. Available from: https:\/\/doi.org\/10.1093\/annonc\/mdx380.029","DOI":"10.1093\/annonc\/mdx380.029"},{"issue":"8","key":"4705_CR19","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/cncr.34113","volume":"128","author":"A Tjokrowidjaja","year":"2022","unstructured":"Tjokrowidjaja A, Lord SJ, John T, Lewis CR, Kok PS, Marschner IC, Lee CK. Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non\u2013small cell lung cancer. Cancer. 2022;128(8):1574\u201383.","journal-title":"Cancer"},{"issue":"4","key":"4705_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/cam4.2024","volume":"8","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Li Y, Yan X, Song Q, Wang G, Hu Y, Jiao S, Wang J. Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. Cancer Med. 2019;8(4):1467\u201373.","journal-title":"Cancer Med"},{"key":"4705_CR21","doi-asserted-by":"crossref","unstructured":"Wang W, Huang Z, Yu Z, Zhuang W, Zheng W, Cai Z, Shi L, Yu X, Lou G, Hong W, Zhang Y, Chen M, Song Z. Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer. Front Oncol. 2020;10(October).","DOI":"10.3389\/fonc.2020.572853"},{"issue":"6","key":"4705_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.21037\/tlcr.2019.11.07","volume":"8","author":"J Ruiz-Ba\u00f1obre","year":"2019","unstructured":"Ruiz-Ba\u00f1obre J, Areses-Manrique MC, Mosquera-Mart\u00ednez J, Cortegoso A, Afonso-Afonso FJ, De Dios-\u00c1lvarez N, Fern\u00e1ndez-N\u00fa\u00f1ez N, Azpitarte-Raposeiras C, Amenedo M, Santom\u00e9 L, F\u00edrvida-P\u00e9rez JL, Garc\u00eda-Campelo R, Garc\u00eda-Gonz\u00e1lez J, Casal-Rubio J, V\u00e1zquez S. Evaluation of the lung immune prognostic index in advanced nonsmall cell lung cancer patients under nivolumab monotherapy. Transl Lung Cancer Res. 2019;8(6):1078\u201385.","journal-title":"Transl Lung Cancer Res"},{"key":"4705_CR23","doi-asserted-by":"crossref","unstructured":"Guven DC, Sahin TK, Erul E, Cakir IY, Ucgul E, Yildirim HC, Aktepe OH, Erman M, Kilickap S, Aksoy S, Yalcin S. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy. J Clin Med. 2022;11(15).","DOI":"10.3390\/jcm11154523"},{"key":"4705_CR24","doi-asserted-by":"crossref","unstructured":"Nelli F, Fabbri A, Virtuoso A, Giannarelli D, Giron Berrios JR, Marrucci E, Fiore C, Ruggeri EM. Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade. Cancers (Basel). 2024;16(2).","DOI":"10.3390\/cancers16020453"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04705-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:54:46Z","timestamp":1774616086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4705"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04705-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Erciyes University Health Sciences Research Ethics Committee (Decision No. 2025\/315). Due to the retrospective nature of the study and minimal risk to patients, the requirement for informed consent was waived by the Erciyes University Health Sciences Research Ethics Committee. All procedures were conducted in accordance with the ethical standards of the institutional and national research committees and with the 1975 Declaration of Helsinki, as revised in 2013. Patient data were fully anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"490"}}